Detox Dr. Oral Clean Care

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications or usage specifications provided. Healthcare professionals are advised to refer to the latest clinical data and guidelines for appropriate prescribing information. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product is indicated for dental use only. Healthcare professionals should ensure that the administration is restricted to the oral cavity and related dental procedures. Proper techniques for preparation and application should be followed to ensure safety and efficacy. It is essential to adhere to the recommended guidelines for dosage and administration specific to the dental context.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children to prevent accidental ingestion or misuse.

Warnings and Precautions

Caution is advised regarding the use of this toothpaste due to its fluoride content, which is 90.5 ppm. Users should take care to avoid swallowing the product and are encouraged to rinse their mouths thoroughly after use. In the event of gum or mouth damage resulting from the use of this toothpaste, it is imperative to discontinue use and seek consultation from a healthcare professional, such as a doctor or dentist.

For children under the age of six years, it is recommended to use only a small amount of toothpaste, approximately the size of a pea, and to ensure that usage occurs under the supervision of a guardian to prevent sucking or swallowing. If a child under six years old ingests a large quantity of toothpaste, immediate consultation with a physician or dentist is necessary. Additionally, this product should be kept out of reach of children under six years old to prevent accidental ingestion.

This toothpaste contains sodium benzoate, which may cause slight irritation to the skin, eyes, and mucous membranes. Furthermore, due to the presence of fluoride and ethanol, guidance from parents or adults is essential when this product is used by children. It is also important to note that the ethanol content may interfere with the results of ethanol testing; therefore, caution should be exercised when conducting alcohol measurements immediately after use of this product.

Side Effects

Patients should be aware that sodium benzoate may cause slight irritation to the skin, eyes, and mucous membranes. This reaction has been noted in clinical settings, and while it is generally considered mild, caution is advised when handling the substance to minimize exposure and potential discomfort.

Drug Interactions

The presence of ethanol in this product may interfere with the accuracy of ethanol testing. Caution is advised when conducting ethanol measurements immediately following the use of this product, as it may yield misleading results regarding alcohol consumption. It is recommended to allow sufficient time after using the product before performing any ethanol testing to ensure accurate assessment.

Packaging & NDC

Below are the non-prescription pack sizes of Detox Dr. Oral Clean Care (allantoin, sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be supervised when using this product, particularly those under the age of six years. It is recommended that a small amount of toothpaste, approximately the size of a pea, be used at a time to minimize the risk of swallowing. In the event that a child under six years old swallows a large amount, immediate consultation with a physician or dentist is advised.

This product contains fluoride and ethanol, necessitating guidance from parents or guardians during use. Additionally, it is crucial to keep this product out of reach of children under six years old to prevent accidental ingestion.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be informed of the absence of established safety data during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine the safety profile in this population.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In cases of overdosage, immediate medical consultation is crucial, particularly for pediatric patients. If a child under the age of 6 years ingests a significant quantity of the medication, it is imperative to seek advice from a physician or dentist without delay.

Healthcare professionals should be aware of the potential symptoms that may arise from an overdosage, although specific symptoms were not detailed in the provided information. It is essential to monitor the patient closely for any adverse effects and to initiate appropriate management procedures based on clinical judgment and established protocols.

In all instances of suspected overdosage, prompt evaluation and intervention are recommended to mitigate potential risks and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in configurations suitable for dental use only. It is essential to keep the product out of reach of children to ensure safety.

Storage conditions should be carefully observed to maintain product integrity. Specific temperature ranges and container requirements are not provided; however, general best practices for storage should be followed. Special handling needs may apply, and healthcare professionals are advised to consult relevant guidelines to ensure proper management of the product.

Additional Clinical Information

Patients should hold a suitable amount of the product (10-15 ml) in their mouth for approximately 30 seconds before spitting it out and brushing their teeth. It is crucial for patients to avoid swallowing the product and to rinse their mouths thoroughly after use. If any gum or mouth damage occurs, patients are advised to discontinue use and consult a healthcare professional.

For children under six years of age, a small amount of toothpaste, approximately the size of a pea, should be used under the supervision of a guardian to prevent sucking or swallowing. In the event that a child swallows a large amount, immediate consultation with a physician or dentist is recommended. The product should be kept out of reach of young children. Additionally, clinicians should note that the product contains sodium benzoate, which may cause slight irritation to the skin, eyes, and mucous membranes, as well as fluoride and ethanol, necessitating adult guidance during use by children. Caution is advised when testing for ethanol (alcohol) immediately after use, as this product may influence the results of drinking measurements.

Drug Information (PDF)

This file contains official product information for Detox Dr. Oral Clean Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)